Wednesday, February 10, 2021   News fundraising

Ractigen Therapeutics closes on $17 Million Series A to advance lead program into clinical phase, led by Hillhouse Venture Capital

[2/11/2021, Nantong] Ractigen Therapeutics, a leading company in the saRNA drug space, announced that it has closed a 17$ million...

News and events

Sunday, June 18, 2017   News

Ractigen Therapeutics officially opens its door for business

[Rudong, China] The grand opening ceremony of Ractigen Therapeutics took place on the morning of June 18th, 2017 in front of Ractigen’s building in the Life-Health Industrial Park, Rudong, Jiangsu. Among the attendants were industrial leaders, industrial and academic experts in the...

Sunday, April 30, 2017   News

HS Talk published a lecture presented by Ractigen’s co-founder and CEO, Dr. Long-Cheng Li

Henry Stewart Talks which publishes animated audio visual presentations by world leading experts published a lecture by Dr. Long-Cheng Li. This lecture entitled "Activation of gene expression by double-stranded RNAs" was recorded at the invitation of HS Talks and can be viewed at this URL:...

Friday, September 2, 2016   News

Ractigen Therapeutics officially incorporated

On September 2, 2016, Ractigen Therapeutics was officially incorporated and registered with the Industry and Commerce Bureau of Nantong, Jiangsu Province.